Abbvie Inc
NYSE:ABBV
Abbvie Inc
Inventory
Abbvie Inc
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Inventory
$4.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Inventory
$1.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
17%
|
CAGR 10-Years
1%
|
|
Amgen Inc
NASDAQ:AMGN
|
Inventory
$9.5B
|
CAGR 3-Years
35%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Inventory
$738.8m
|
CAGR 3-Years
38%
|
CAGR 5-Years
43%
|
CAGR 10-Years
49%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Inventory
$2.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
18%
|
CAGR 10-Years
43%
|
|
Seagen Inc
NASDAQ:SGEN
|
Inventory
$531.2m
|
CAGR 3-Years
76%
|
CAGR 5-Years
48%
|
CAGR 10-Years
35%
|
See Also
What is Abbvie Inc's Inventory?
Inventory
4.1B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Inventory amounts to 4.1B USD.
What is Abbvie Inc's Inventory growth rate?
Inventory CAGR 10Y
14%
Over the last year, the Inventory growth was 15%. The average annual Inventory growth rates for Abbvie Inc have been 7% over the past three years , 21% over the past five years , and 14% over the past ten years .